Objective Continuous positive airway pressure (CPAP) is an effective treatment for obstructive sleep apnea (OSA). After performing an initial titration study, most physicians do not have the CPAP equipment retitrated unless the patient complains about the CPAP use. Several automated CPAP devices are used clinically that can detect upper airway obstructive events and provide information about residual events while patients are on CPAP. The aim of this study was to compare the apnea-hypopnea index (AHI) determined by automated CPAP devices to that obtained from polysomnography. Methods Patients with OSA underwent polysomnography for CPAP titration using the REMstar Auto Mseries. The initial two hours of CPAP titration were spent at a subtherapeutic pressure of 4 cmH2O so that more breathing events could be observed. The correlations between the simultaneous determination of the AHI with polysomnography (AHI-PSG) and the automated device (AHI-RAM) during the subtherapeutic, therapeutic and overall phases were evaluated. In addition, the apnea index (AI) and the hypopnea index (HI) were each evaluated separately. Results Sixty patients were enrolled. The mean AHI on diagnostic PSG was 35.2±2.6 events/hour. Strong correlations were observed between the AHI-PSG and the p<0.001; therapeutic: r=0.824, p<0.001; overall: r=0.927, p<0.001). A slightly stronger correlation was observed between the AI values, whereas a weaker correlation was observed between the HI values in all three phases. Conclusion Strong correlations between the AHI-PSG and the AHI-RAM were observed. The correlations were weakened when the analysis was limited to the HI and the therapeutic phase.
Introduction
Continuous positive airway pressure (CPAP) has been established as an effective treatment for obstructive sleep apnea (OSA), a common disorder associated with increased mortality (1-3). Many reports have described the alleviation of symptoms associated with OSA (4-7) and the reduction of overall mortality in patients with OSA with the use of CPAP (8) . Therefore, CPAP has been used globally to suppress OSA for the past two decades.
Standard sleep medicine practice involves the manual titration of CPAP by a sleep technologist during attended inlaboratory polysomnography in order to determine the optimal pressure level for the alleviation of sleep-related respiratory events (9) . However, most physicians do not have the CPAP equipment retitrated after performing the initial titration study unless the patient complains about the CPAP use.
Sleep Center, Toranomon Hospital, Japan, Clinical Physiology, Toranomon Hospital, Japan, Cardio-Respiratory Sleep Medicine, Department of Cardiology, Juntendo University, School of Medicine, Japan and Cardiovascular Center, Toranomon Hospital, JapanIt has been reported that persistent OSA on CPAP frequently occurs, even in patients without obvious symptoms, and is more prevalent in patients with high body mass indices, higher prescribed pressures and unresolved mask leaks (10) . Therefore, CPAP reassessment should be performed in more subjects, although repeating in-laboratory polysomnography in all subjects would be costly and labor intensive.
Currently, several CPAP devices designed to detect upper airway obstruction and provide information regarding the residual apnea-hypopnea index (AHI) while wearing CPAP have come into clinical use. Using this type of device, residual AHI data on CPAP can be easily download. However, there is little evidence regarding the accuracy of respiratory event detection technology in such devices, especially while the patients are on CPAP (11, 12) . In addition, respiratory event detection technology is specific to the manufacturer, the software and the version of the device. In this regard, the accuracy of the residual AHI determined by the REMstar Auto M Series (Respironics Inc, Murrysville, PA, USA)
has not yet been fully assessed. Furthermore, data on the factors that affect the correlation between the AHI scored on polysomnography and that determined by the device are sparse. The aim of this study was to compare the residual AHI on CPAP determined by the REMstar Auto M Series with that obtained on manually scored standard in-laboratory polysomnography and to identify the factors that affect the correlation between the AHI scored on polysomnography and that determined by the REMstar Auto M Series.
Materials and Methods

Subjects
Consecutive patients from our sleep center (Toranomon Hospital, Tokyo, Japan) with moderate to severe OSA determined on diagnostic polysomnography who were followed with overnight titration using the REMstar Auto M Series device were enrolled between September 2007 and February 2008. The exclusion criteria were: 1) patients with heart failure or previous stroke and those on dialysis; 2) patients with a central AHI of more than five events/hour with at least 10% of the total AHI coming from central events; and 3) patients who experience any central events on CPAP titration.
The Toranomon Hospital Ethics Committee approved the study, and informed consent to participate was obtained from all patients.
Measurements and protocol
Polysomnography was performed in the sleep laboratory using a digital polygraph (SomnoStar Pro Sleep System; VI-ASYS Health Care, Yorba Linda, CA, USA) monitored by a sleep technician. The following accepted definitions and scoring methods for the diagnosis of OSA were used for both diagnostic polysomnography and CPAP titration: apnea was defined as a cessation of airflow for 10 seconds or more and hypopnea was defined as a reduction of airflow by more than 50% for 10 seconds or more or a discernible reduction of airflow with desaturation or arousal (13, 14) . During CPAP titration, polysomnography was performed while the patients wore the RAM with a nasal mask. Therefore, the polysomnographic airflow signals were obtained from the nasal mask of the CPAP device through a digital polygraph interface (Analog Output Module, Respironics, Inc). The pressure level was titrated manually using the standard titration procedure (15) (16) (17) .
The REMstar Auto M Series device automatically detected the flatness, roundness, peak and shape of the flow signal in order to identify flow limitation as well as snore vibrations. Apneas and hypopneas were also detected according to the following definitions: apnea events were scored when a decrease in airflow longer than 10 seconds and greater than 80% of the baseline established based on the moving airflow signal window in each individual was detected and hypopnea events were scored when a decrease in airflow longer than 10 seconds and greater than 40% of the baseline was observed followed by a recovery breath. Data on all detected respiratory events were outputted through an Analog Output Module and recorded on the digital polygraph system simultaneously with information on the device pressure and leakage during CPAP titration.
During overnight CPAP titration, the initial two hours or the period until the end of the first REM sleep were spent at a fixed subtherapeutic pressure of 4 cmH2O (subtherapeutic phase) so that more breathing events could be observed. After the initial subtherapeutic phase was completed, the device was set to adjust the CPAP pressure as needed throughout the remainder of the night (therapeutic phase). All polysomnographic (PSG) recordings were scored by the same registered polysomnographic technologist with the devicegenerated respiratory event channel hidden. In each case, the numbers of apneas and hypopneas were scored and the AHI (AHI-PSG) was calculated per hour of sleep. The apnea index (AI-PSG) and hypopnea index (HI-PSG) were also determined in total and separately during the therapeutic and subtherapeutic phases. Then, the hidden device breathing event channel was visualized and the numbers of apneas and hypopneas determined by the REMstar Auto M Series (RAM) were manually scored by another investigator who was blind to the polysomnographic scores. The AHI determined by the RAM (AHI-RAM) was calculated per hour of recording, and the apnea index (AI-RAM) and hypopnea index (HI-RAM) were calculated in total and separately during the therapeutic and subtherapeutic phases. Data on leakage and the provided pressure level (average and 95% of leakage or provided pressure) were also obtained.
Statistical analysis
The data are expressed as the mean ± standard error of mean (SEM) for continuous variables or numbers and percentages for categorical variables. The data derived from PSG and those from RAM were compared using the Wil- coxon rank-sum test. The correlations and agreements between the AHI-PSG and the AHI-RAM, as well as those between the AI-PSG and the AI-RAM and the HI-PSG and the HI-RAM, were assessed with a regression analysis and Bland and Altman plots (18) . The subjects were divided into two subgroups according to gender and median age, body mass index (BMI), AHI in the diagnostic study, the mean of AHI-PSG and AHI-RAM, leakage and provided pressure during each phase. In order to assess whether there were differences in the correlations between the AHI-PSG and the AHI-RAM, an analysis of covariance, including an interaction term, was performed. P-values of less than 0.05 were considered to be statistically significant.
Results
A total of 60 patients were enrolled. The characteristics and findings of diagnostic polysomnography are shown in Table 1 . The mean overall total sleep time and mean total recording time were 5.0±0.1 hour and 5.7±0.1 hour, respectively. In addition, the mean total sleep time during the subtherapeutic and therapeutic phases was 1.3±0.1 hour and 3.7±0.1 hour, respectively. The mean total recording time during the subtherapeutic and therapeutic phases was 1.5± 0.1 hour and 4.2±0.1 hour, respectively. The polysomnographic findings and data obtained from the REMstar Auto M Series during CPAP titration are shown in Tables 2, 3 , respectively.
During the subtherapeutic phase, the mean AHI-PSG was 21.8±3.7 events/h, whereas the mean AHI-RAM was 22.8± 3.4 events/h (p=0.331). Fig. 1a shows the correlation between the AHI-PSG and AHI-RAM values (r=0.958; p< 0.001). Fig. 1b shows a Bland and Altman plot that showed a mean AHI difference of -1.0±1.1 events/h. The limits of agreement for the AHI ranged from -17.4 to 15.4. The mean AI-PSG was 10.9±2.9 events/h, whereas the mean AI-RAM was 13.9±3.0 events/h (p<0.001). Fig. 2a shows the correlation between the AI-PSG and AI-RAM values (r=0.979; p< 0.001). Fig. 2b shows a Bland and Altman plot that showed a mean AI difference of -3.0±0.6 events/h. The limits of agreement for the AI ranged from -12.6 to 6.6. The mean HI-PSG was 10.9±1.6 events/h, whereas the mean HI-RAM was 9.0±1.1 events/h (p=0.074). Fig. 3a shows the correlation between the HI-PSG and HI-RAM values (r=0.646; p< 0.001). Fig. 3b shows a Bland and Altman plot that showed a mean HI difference of 2.0±1.2 events/h. The limits of agreement for the HI ranged from -16.8 to 20.8. The pressure was fixed at 4 cmH2O according to the study protocol. No significant leakage was observed during the subtherapeutic phase. The interactions between the two AHI correlations (i.e. correlations between AHI-RAM and AHI-PSG) and age and gender were significant (p=0.004 and p=0.001, respec- During the therapeutic phase, the mean AHI-PSG was 3.8±0.6 events/h, whereas the mean AHI-RAM was 4.8±0.5 events/h (p=0.009). Fig. 4a shows the correlation between the AHI-PSG and AHI-RAM values (r=0.824; p<0.001). Fig. 4b shows a Bland and Altman plot that showed a mean AHI difference of -0.9±0.3 events/h. The limits of agreement for the AHI ranged from -5.9 to 4.1. The mean AI-PSG was 1.6±0.3 events/h, whereas the mean AI-RAM was 2.3±0.3 events/h (p<0.001). Fig. 5a shows the correlation between the AI-PSG and AI-RAM values (r=0.830; p< 0.001). Fig. 5b shows a Bland and Altman plot that showed a mean AI difference of -0.7±0.2 events/h. The limits of agreement for the AI ranged from -3.5 to 2.1. The mean HI-PSG was 2.2±0.4 events/h, whereas the mean HI-RAM was 2.5±0.3 events/h (p=0.263). Fig. 6a shows the correlation between the HI-PSG and HI-RAM values (r=0.651; p< 0.001). Fig. 6b shows a Bland and Altman plot that showed a mean HI difference of -0.2±0.3 events/h. The limits of agreement for the HI ranged from -4.4 to 4.0. The average and 95% pressures provided during the therapeutic phase were 7.4±0.3 and 10.2±0.4 cmH2O, respectively. The amount of leakage observed during the therapeutic phase was acceptable. No significant interactions were observed between the two AHI correlations and all subgroup categories.
Overall, the mean AHI-PSG was 8.1±1.2 events/h, whereas the mean AHI-RAM was 9.4±1.1 events/h (p= 0.025). Fig. 7a shows the correlation between the AHI-PSG and AHI-RAM values (r=0.927; p<0.001). Fig. 7b shows a Bland and Altman plot that showed a mean AHI difference of -1.3±0.4 events/h. The limits of agreement for the AHI ranged from -8.1 to 5.5. The mean AI-PSG was 3.8±0.9 events/h, whereas the mean AI-RAM was 4.9±0.9 events/h (p<0.001). Fig. 8a shows the correlation between the AI-PSG and AI-RAM values (r=0.959; p<0.001). Fig. 9b shows a Bland and Altman plot that showed a mean AI difference of -1.1±0.3 events/h. The limits of agreement for the AI ranged from -5.1 to 2.9. The mean HI-PSG was 4.3±0.5 events/h, whereas the mean HI-RAM was 4.5±0.4 events/h (p=0.860). Fig. 9a shows the correlation between the HI- Fig. 9b shows a Bland and Altman plot that showed a mean HI difference of -0.2±0.4 events/h. The limits of agreement for the HI ranged from -7.0 to 6.6. The average and 95% pressures provided during the therapeutic phase were 6.4±0.2 and 9.8±0.3 cmH2O, respectively. The amount of overall leakage was acceptable. The interactions between the two AHI correlations and BMI and the averages of AHI-PSG and AHI-RAM were significant (p=0.049 and p=0.026, respectively), indicating that subjects with higher BMIs or greater average AHIs had stronger correlations between AHI-PSG and AHI-RAM than those with lower BMIs or lower average AHIs.
Discussion
In the present study, we found that the indices of respiratory events determined by the REMstar Auto M Series highly correlated with those derived from polysomnography during the subtherapeutic period, which had a fixed minimal pressure in order to observe more breathing events. The indices of respiratory events determined by the REMstar Auto M Series were identical to those derived from polysomnography (the differences between the two were -1 for AHI, -3 for AI and +2 for HI). During the therapeutic pressure setting, the correlations between the indices of respiratory events determined by the REMstar Auto M Series and those derived from polysomnography were slightly attenuated; however, the REMstar Auto M Series still provided indices of respiratory events that were similar to those derived from polysomnography (the differences between the two were -0.9 for AHI, -0.7 for AI and -0.3 for HI) and were within an acceptable range of the limit of agreement. Overall, strong correlations were observed between the indices of respiratory events determined by the REMstar Auto M Series and those derived from polysomnography (the differences between the two were -1.3 for AHI, -1.1 for AI and -0.2 for HI) that were within an acceptable range of the limit of agreement. Compared with those of the AHI and the AI, the correlations in the HI were generally attenuated in all study phases (subtherapeutic, therapeutic and overall). Furthermore, we found that age and gender affected the correla- tion between the AHI-PSG and the AHI-RAM at the subtherapeutic pressure level and that BMI and the severity of the OSA at the initial diagnostic study affected the overall correlation between the AHI-PSG and the AHI-RAM. These results are important for determining whether respiratory events are optimally suppressed clinically with the prescribed pressure setting after the initiation of CPAP therapy by downloading the residual AHI from the REMstar Auto M Series device.
Several types of CPAP devices designed to detect upper airway obstruction and provide the residual AHI while wearing CPAP have been used clinically. The possibility of replacing the diagnostic evaluations performed with polysomnography with those using a CPAP device has been investigated in earlier studies (19) (20) (21) . However, only a few studies have examined the accuracy of respiratory event detection technology, especially while patients are on CPAP (11, 12) . Our group has previously evaluated the AHIs determined by different types of CPAP devices compared to those derived from polysomnography in order to examine the accuracy of the residual AHI downloaded from the CPAP device (11). However, it is well known that these technologies are manufacturer-and device-generation specific. Prasad and colleagues evaluated the accuracy of detection of residual apnea and hypopnea events on a CPAP device made by the same manufacturer as the REMstar Auto M Series (12) . In their study, only 10 subjects were enrolled and an oldergeneration device was used. In addition, because the aim of their study was to assess the accuracy of the respiratory event detection algorithm, the total numbers of apnea and hypopnea events, rather than the indices of respiratory events (i.e. AHI, AI and HI) were analyzed. According to that event-by-event basis analysis, the number of respiratory events was identical, both at the subtherapeutic and therapeutic phases; however, the correlations between the two detection methods were poor for both apneas and hypopneas, especially during the therapeutic phase. The authors suggested that the attenuation of the correlations at the therapeutic phase might be due to decreases in the total number of respiratory events and increases in leakage during the therapeutic phase. However, in the clinical setting, CPAP devices are used at home for variable time intervals. This indi- cates that the total number of respiratory events is not a good measure to assess whether the respiratory event detection technology is clinically applicable. In this respect, indices of respiratory events occurring while wearing CPAP are more relevant. Furthermore, the accuracy of the indices of respiratory events determined by the CPAP device based on the total recording time rather than the total sleep time may be of clinical importance. We herein assessed the accuracy of the indices of respiratory events determined by the REMstar Auto M Series based on the total recording time and those derived from polysomnography and found that the AHI-RAM could be clinically applicable for evaluating residual respiratory events, even on the therapeutic pressure level.
Considering the results of the specific analysis of the HI, the correlations between HI-RAM and HI-PSG were generally poor in all phases. This result is compatible with the findings of previous studies, regardless of the study protocol and the type of CPAP device (11, 12, (19) (20) (21) . The poor correlation in HI is not unexpected if we take into account the differences in the scoring methods used between the REMstar Auto M Series and polysomnography. Some borderline airflow reductions that fail to qualify as a hypopnea in polysomnography scoring are scored as hypopnea by the REMstar Auto M Series. Conversely, because the REMstar Auto M Series scores hypopnea events by the airflow signal only, some subtle airflow reductions that fail to qualify as a hypopnea in the REMstar Auto M Series scoring score as hypopnea on polysomnography if arousal or desaturation occurs. Furthermore, some hypopnea events that occur during sleep-wake transition periods are not scored by polysomnography but are scored by the REMstar Auto M Series. The difference in the time interval between total sleep time and total recording time also affects these correlations.
In the present study, the interactions between the two AHI correlations and the subgroup categories were assessed. The subgroup categories that showed significant interactions included age and gender in the subtherapeutic phase and BMI and the average of the AHI-RAM and the AHI-PSG in the overall phase, indicating that younger subjects and men had stronger AHI correlations than older subjects and women during the subtherapeutic phase and that subjects with higher BMIs or greater average AHIs had stronger AHI correlations than those with lower BMIs or lower average AHIs. These results imply that the correlations between the AHI-RAM and the AHI-PSG were generally stronger in patients who were more likely to have more severe OSA in either the diagnostic study or the titration study than in patients with less severe OSA. These issues should be taken into account when evaluating the residual AHI on CPAP in the clinical setting.
There were some limitations associated with the present study. We excluded patients with central events on CPAP titration because the algorithm of the REMstar Auto M Series device was designed for the detection of upper airway obstructive events and cannot detect central events with confidence. This may have favorably influenced the correlations between the indices of respiratory events determined by the REMstar Auto M Series and those derived from polysomnography. Because the sleep study on CPAP was performed in an in-laboratory and attended situation in this study, these results must be interpreted with caution in the domiciliary setting.
In conclusion, strong correlations between the AHI-RAM and the AHI-PSG were observed, whereas such correlations became weaker when the analysis was limited to the HI. In addition, these correlations may be attenuated in patients with less severe OSA and lower residual AHIs on CPAP. These results are useful for follow-up of OSA patients using CPAP and indicate that CPAP reassessment is a costeffective management tool for some patients.
